BioOra Limited
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Biotech manufacturer commercialising 3rd gen CAR-T cell therapy for NZ cancer patients and medical tourism from a bespoke site in Christchurch, New Zealand. BioOra hold an exclusive license to commercialise (and sell) a novel 3rd generation CAR which has a significantly better safety profile than competitors but with equivalent efficacy. The Phase 1 clinical trials were completed in 2024 and Phase 2 is underway across 3 trial sites in NZ, and for 60 patients with NHL. BioOra are the exclusive manufacturer for the trial and have commercial rights thereafter for manufacturing and supply in NZ and Australia. BioOra hold the INN and are negotiating with local regulators for approval and with central payers for public delivery.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}